公开(公告)号：US20210196196A1

公开(公告)日：2021-07-01

申请号：US17202354

申请日：2021-03-16

申请人： TWIN HEALTH, INC.

发明人： Terrence Chun Yin Poon ,  Amit Shrivastava ,  Jahangir Mohammed ,  Lihuan Xie

IPC分类号： A61B5/00 ,  G16H15/00 ,  A61B5/11 ,  A61B5/145 ,  G16H50/30 ,  G16H40/67 ,  G16H20/10 ,  G16H20/60 ,  G16H50/20 ,  G16H10/40 ,  G16H50/50 ,  G16H10/60 ,  G06N20/00

摘要： A patient health management platform determines of a metabolic state for a first time period. The platform generates a patient-specific treatment recommendation for a second time period following the first time period that identifies objectives for the patient to complete to improve the metabolic state determined for the first time period. Periodically during the second time period, the platform receives recordings of patient data indicating foods consumed by the patient, medication taken by the patient, and/or symptoms experienced by the patient. The platform compares the received recordings of patient data from the second time period to the generated patient-specific treatment recommendation to determine a number of objectives completed by the patient and updates a score representing n adherence of the patient to the patient-specific treatment recommendation based the number of completed objectives. The platform provides the patient-specific treatment recommendation to the patient device for display to the patient.

公开(公告)号：US11350876B2

公开(公告)日：2022-06-07

申请号：US17202354

申请日：2021-03-16

申请人： TWIN HEALTH, INC.

发明人： Terrence Chun Yin Poon ,  Amit Shrivastava ,  Jahangir Mohammed ,  Lihuan Xie

IPC分类号： A61B5/00 ,  G16H50/30 ,  G16H40/67 ,  G16H50/20 ,  G16H15/00 ,  A61B5/11 ,  A61B5/145 ,  G16H20/10 ,  G16H20/60 ,  G16H10/40 ,  G16H50/50 ,  G16H10/60 ,  G06N20/00 ,  A61B5/0205

摘要： A patient health management platform determines of a metabolic state for a first time period. The platform generates a patient-specific treatment recommendation for a second time period following the first time period that identifies objectives for the patient to complete to improve the metabolic state determined for the first time period. Periodically during the second time period, the platform receives recordings of patient data indicating foods consumed by the patient, medication taken by the patient, and/or symptoms experienced by the patient. The platform compares the received recordings of patient data from the second time period to the generated patient-specific treatment recommendation to determine a number of objectives completed by the patient and updates a score representing n adherence of the patient to the patient-specific treatment recommendation based the number of completed objectives. The platform provides the patient-specific treatment recommendation to the patient device for display to the patient.